Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Regis HealthcareASX:REG -1.66%79 EV-to-EBITDA is 15.49 as of Jul. 15, 2026, which is 93% above its 10-year median of 8.03. GuruFocus rates ASX:REG with a GF Score™ of 79/100 and a GF Value™ of A$10.53 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Regis Healthcare ranks worse than 65.29% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Regis Healthcare's enterprise value is A$3,890 Mil.
Regis Healthcare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$251 Mil. Therefore, Regis Healthcare's EV-to-EBITDA for today is 15.49.
The historical rank and industry rank for Regis Healthcare's EV-to-EBITDA or its related term are showing as below:
ASX:REG'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.28 Med: 8.03 Max: 18.5
Current: 15.49
During the past 11 years, the highest EV-to-EBITDA of Regis Healthcare was 18.50. The lowest was 4.28. And the median was 8.03.
ASX:REG's EV-to-EBITDA is ranked worse than 65.29% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 10.89
vs ASX:REG: 15.49
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Regis Healthcare (ASX:REG) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Regis Healthcare's PE Ratio (TTM) for today is calculated as:
Regis Healthcare's share price for today is A$5.92.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Regis Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.124.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Regis Healthcare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Regis Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Regis Healthcare EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Regis Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Regis Healthcare's EV-to-EBITDA falls into.
Regis Healthcare's current Enterprise Value is A$3,890 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Regis Healthcare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$251 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Regis Healthcare (ASX:REG) has a EV-to-EBITDA of 15.49 as of Jul. 15, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Regis Healthcare. This is 93% above median its historical median of 8.03. Over the past decade, Regis Healthcare's EV-to-EBITDA has ranged from 4.28 to 18.50. According to the industry distribution chart, Regis Healthcare ranks #331 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 65.3%.
Is Regis Healthcare's EV-to-EBITDA too high?
Regis Healthcare's current EV-to-EBITDA of 15.49 is 93% above median its 10-year median of 8.03. Over the past 10 years, this metric has ranged from a low of 4.28 to a high of 18.50. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.89. Regis Healthcare's value of 15.49 is 42.2% above this industry median. Based on the distribution chart, Regis Healthcare ranks #331 out of 507 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Regis Healthcare has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Regis Healthcare's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Regis Healthcare ranks #331 out of 507 companies for EV-to-EBITDA. This places Regis Healthcare in the lower half of its industry. The industry median EV-to-EBITDA is 10.89. Regis Healthcare's value of 15.49 is 42.2% above this benchmark. Historically, Regis Healthcare's own EV-to-EBITDA has ranged from 4.28 to 18.50 over the past decade. While the company's 10-year median is 8.03 vs. the industry median of 10.89, Regis Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.89, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Regis Healthcare's current EV-to-EBITDA of 15.49 is 42.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Regis Healthcare. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regis Healthcare's current EV-to-EBITDA is 15.49, which is 93% above median its own 10-year median of 8.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Regis Healthcare (ASX:REG) is currently considered Possible Value Trap. The stock's GF Value™ is A$10.53, compared to a current price of A$5.92 — trading 43.8% below its estimated fair value. The current EV-to-EBITDA is 15.49, which is 93% above median its 10-year median of 8.03 and 42.2% above the Healthcare Providers & Services industry median of 10.89. Regis Healthcare's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Regis Healthcare (ASX:REG), the current EV-to-EBITDA is 15.49 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Regis Healthcare (ASX:REG) Overvalued in 2026?
Based on GuruFocus' analysis, Regis Healthcare stock appears to be undervalued.
The current stock price of A$5.92 is trading 43.8% below its estimated GF Value™ of A$10.53.
GuruFocus considers Regis Healthcare to be Possible Value Trap.
Key valuation signals for ASX:REG:
EV-to-EBITDA: 15.49 (93% above median its 10-year median of 8.03)
GF Value™: A$10.53 vs. price of A$5.92 (43.8% below fair value)
Industry Position: 42.2% above the Healthcare Providers & Services median (#331 of 507)
No single metric tells the full story. See the ASX:REG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
79GF Score
Get the complete analysis for ASX:REG
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:REG has been successfully added to your 
